Table 4.
The literature review results for autoimmune conditions triggered following the COVID-19.
Autoimmune Disease | Reference | |
---|---|---|
1 | Antiphospholipid syndrome | (42–44) |
2 | Guillain-Barr´e syndrome | (45–47) |
3 | Miller Fisher syndrome | (48, 49) |
4 | Polyneuritis cranialis | (49) |
5 | Thyroid function | (50, 51) |
6 | Graves’ disease | (52) |
7 | Vasculitis | (53) |
8 | Kawasaki disease | (54) |
9 | Type 1 Diabetes | (55–57) |
10 | Autoimmune hemolytic anemia | (58–60) |
11 | Immune thrombocytopenic purpura | (61, 62) |
12 | Systemic lupus erythematosus | (63, 64) |
13 | Post orthostatic tachycardia syndrome | (65) |
14 | Viral arthritis | (66, 67) |
15 | Myasthenia gravis | (68) |
16 | Autoimmune encephalitis | (69) |
17 | Rheumatoid arthritis | (70, 71) |
18 | Autoimmune limbic encephalitis | (72) |
19 | Multiple sclerosis | (73, 74) |
20 | Inflammatory Bowel Disease (Crohn’s disease and ulcerative colitis) | (75) |
21 | Ankylosing spondylitis | (76) |